As expected, all ovarian cancers detected were in MSH2 carriers, consistent with ovarian cancer risk of 17%.3 Screening led to diagnosis in half of the studies (Online Supplemental Figure 3). The gene discussed is MSH2; the disease is ovarian cancer.